Facing adenocarcinoma of distal esophagus and esophagogastric junction: a CROSS versus FLOT propensity score-matched analysis of oncological outcomes in a high-volume institution

Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma

(2022) Sivesh Kathir Kamarajah et al.   ANNALS OF SURGERY

Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About

(2022) Lucy X. Ma et al.   Journal of the National Comprehensive Cancer Network

CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-matched Comparison

(2022) Noel E. Donlon et al.   ANNALS OF SURGERY

An International Cohort Study of Prognosis Associated with Pathologically Complete Response Following Neoadjuvant Chemotherapy versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma

(2022) Jonathan Cools-Lartigue et al.   ANNALS OF SURGERY

Treatment patterns and overall survival for recurrent esophageal or gastroesophageal junctional cancer: A nationwide European population-based study.

(2021) Marieke Pape et al.   JOURNAL OF CLINICAL ONCOLOGY

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma

(2021) Noel E. Donlon et al.   ANNALS OF SURGERY

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis

(2021) Patrick Sven Plum et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?

(2021) Francisco Laxague et al.   World Journal of Clinical Oncology

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

(2019) Salah-Eddin Al-Batran et al.   LANCET

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

(2019) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Gastro-oesophageal junction: to FLOT or to CROSS?

(2019) Tom van den Ende et al.   ACTA ONCOLOGICA

Multimodality treatment for esophageal adenocaricnoma: multi-center propensity-score matched study

(2016) S. R. Markar et al.   ANNALS OF ONCOLOGY

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

(2016) Jens Hoeppner et al.   BMC CANCER

International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy

(2015) Donald E. Low et al.   ANNALS OF SURGERY

Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status

(2015) M. Scarpa et al.   DISEASES OF THE ESOPHAGUS

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas

(2011) Karen Becker et al.   ANNALS OF SURGERY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Peri-operative care series

(2011) Jyoti Shah et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: Does the pattern of recurrence differ for patients with complete response and those with partial or no response?

(2009) Robert A. Meguid et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY